Wed, Nov 04, 2026 - Page 34
24697 indexed SquawkNews stories from this UTC day. Showing 3961-4080.
M
BillionToOne Reports Third-Quarter Results, Raises 2026 Revenue Guidance
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Hamilton Beach Brands Reports Third-Quarter Revenue of $140.3M
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
a.k.a. Brands Reports Q3 Sales Up 9.7%, Adjusted EBITDA Nearly 17% Higher
Third-quarter net sales grew 9.7% and adjusted EBITDA increased nearly 17%. Gross margin expanded approximately 100 basis points to 60.1%.
EARNINGS | Nov 04, 2026, 09:08 PM UTC
L
Adaptive Biotechnologies Reports Third-Quarter EPS
EARNINGS | Nov 04, 2026, 09:08 PM UTC
L
BioCryst Pharmaceuticals Files Form 10-Q
BioCryst Pharmaceuticals filed a Form 10-Q for the period ended September 30.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
NETGEAR Guides Q4 Revenue to $160M–$175M
NETGEAR reported Q3 non-GAAP EPS of $0.13, versus $0.12 a year earlier, and non-GAAP operating income of $3.3 million, versus $3.8 million. It expects a Q4 non-GAAP operating margin of 0%–3%.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Cirrus Logic Reports Fiscal Second-Quarter Revenue of $559.5 Million
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Vir Biotechnology Reports Q3 Net Loss of $96.3 Million
Vir reported a Q3 2026 net loss of $96.3 million, or $0.57 per share, compared with $163.1 million, or $1.17 per share, in Q3 2025. It had approximately $901.3 million in cash, cash equivalents and investments, which it
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Emergent BioSolutions Receives $22.3 Million BioThrax Order Modification
The company said the modification exercises an option period under an existing delivery order to supply BioThrax to the U.S. Department of War.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Solaris Energy Infrastructure Reports Q3 Results, Adds Power Contracts and Raises Guidance
Solaris announced third-quarter 2026 results, additional power contracts and increased guidance.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Corpay Reports Third-Quarter Financial Results
Corpay reported third-quarter results for the period ended September 30, 2026. The company said revenue grew 18% and adjusted net income per diluted share grew 32%, both ahead of its expectations.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Sturm, Ruger Q3 Adjusted EBITDA Rises 401.9% to $14.3M
Sturm, Ruger reported Q3 adjusted EBITDA of $14.3 million, up from $2.9 million a year earlier. Its board declared a $0.18-per-share dividend, about 40% of adjusted net income of $0.44 per share.
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
electroCore reports third-quarter loss per share
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
electroCore Reports Third-Quarter Sales of $9.69 Million
EARNINGS | Nov 04, 2026, 09:08 PM UTC
L
Hewlett Packard Enterprise files Form 8-K
Hewlett Packard Enterprise filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
ADMA Biologics Reports Third-Quarter 2026 Financial Results
ADMA reported third-quarter 2026 revenue of $141.1 million, up 5% year over year. The supplied update also lists ASCENIV revenue of $12, with no unit or further context provided.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Regeneron Form 4 Filed by Joseph J. LaRosa
A Form 4 for Regeneron, covering Nov. 2, was filed Nov. 4 by Joseph J. LaRosa.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
ACADIA Pharmaceuticals Reports $342.3M in Third-Quarter Revenue
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Titan America Announces Third-Quarter 2026 Results
Titan America announced its third-quarter 2026 financial results.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
American Superconductor Reports $94M in Second-Quarter Revenue
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
American Superconductor Reports $3M Net Income in 2Q
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
Vaxcyte Reports Q3 2026 Results, Positive VAX-31 Phase 3 Topline Data
Vaxcyte reported third-quarter 2026 financial results and announced positive topline data from the OPUS-1 pivotal Phase 3 trial for VAX-31’s adult indication.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
American Superconductor Reports 2Q EPS
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
ACADIA Pharmaceuticals reports third-quarter net income of $53.5 million
EARNINGS | Nov 04, 2026, 09:08 PM UTC
L
ACADIA Pharmaceuticals reports third-quarter EPS
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
Xperi Raises 2026 EBITDA Margin and Cash Flow Outlook
Xperi narrowed its 2026 revenue outlook while raising its outlook for adjusted EBITDA margin and operating cash flow. The release provided no figures.
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
8x8 Reports Record Revenue in Fiscal Q2 2027
8x8 reported financial results for the quarter ended September 30, 2026, and said revenue grew year over year for a sixth consecutive quarter.
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
NETGEAR Reports Third-Quarter 2026 Results
NETGEAR reported results for the quarter ended September 27, 2026, including non-GAAP gross margin of 41.3%, up 170 basis points year over year.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Dianthus Therapeutics reports Q3 revenue of $1.21M
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Aeva Reports Third-Quarter 2026 Results
Aeva said record third-quarter revenue was driven by record volume of its 4D LiDAR and optical solutions and manufacturing scale-up.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Credit Acceptance Director Reports $1.46 Million Share Acquisition
Director Thomas N. Tryforos reported acquiring $1.46 million in Credit Acceptance common shares.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Schrödinger Reports Third-Quarter 2026 Financial Results, Raises Outlook
Schrödinger reported 17% ACV growth and $24 million in drug discovery revenue, and raised its full-year ACV and drug discovery revenue outlook.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
FrontView REIT Reports Third-Quarter 2026 Results
FrontView said it delivered AFFO per share of $0.33 and acquired 16 properties at a 7.6% cap rate during the quarter ended September 30, 2026.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Vaxcyte Reports Third-Quarter Loss of $297.1 Million
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Super Group to Participate in Investor Conferences
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Vir Biotechnology Reports Third-Quarter 2026 Financial Results
Vir Biotechnology reported financial results for the quarter ended September 30, 2026. The supplied body is truncated and provides no financial figures.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
OnKure Therapeutics Reports Third-Quarter 2026 Financial Results
OnKure Therapeutics also announced PANORAMA, an OnKure-sponsored, large-scale, multiregional registry. The supplied body is truncated before describing its purpose.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
AstraZeneca Made $10 Billion Offer For Rhythm Pharmaceuticals — WSJ
READ HERE
NEWS | Nov 04, 2026, 09:08 PM UTC
M
Caris Life Sciences Reports 3Q Revenue of $275.4M
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
Magnolia Oil & Gas Reports Q3 Revenue of $513.9M
Q3 revenue was $513.9 million, versus a FactSet estimate of $474.4 million.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Xperi Announces Third-Quarter 2026 Results
Xperi announced financial results for the quarter ended September 30, 2026.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Power Integrations Reports Third-Quarter Results
Revenue increased sequentially to $125.5 million; GAAP earnings were $0.32 per diluted share.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Red Violet Reports Third-Quarter Revenue of $27.8 Million
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Robinhood to Present at Wolfe Research Wealth Symposium November 11
Robinhood Markets said it will present at the Wolfe Research Wealth Symposium on November 11, 2026.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Vertex Reports Third-Quarter Revenue of $213.3 Million
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Acadia Reports Third-Quarter 2026 Financial Results
Acadia reported third-quarter revenue of $342 million, citing continued commercial momentum across DAYBUE and NUPLAZID.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Sabra Health Care REIT to Attend Nareit’s REITworld 2026 Conference
Sabra Health Care REIT announced it will attend Nareit’s REITworld 2026 Annual Conference.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Xperi Reports Third-Quarter Revenue of $114 Million
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Red Violet Reports Third-Quarter EPS
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
Silvaco Reports Third-Quarter 2026 Financial Results
Silvaco said it won a major new tier-1 FTCO customer and four tier-1 customers for Jivaro Pro in Q3. The body also mentions record revenue but is truncated before giving a figure or complete outlook.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Chesapeake Granite Wash Trust Announces $0.0154 Per-Unit Distribution
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Xperi Reports $5.24 Million Third-Quarter Loss
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Chiron Real Estate Reports 1.6% Third-Quarter Medical-Portfolio NOI Growth
Same-property cash NOI in the outpatient medical portfolio rose 1.6% year over year. Debt was $661.7 million, and leverage was 41.2% of gross assets, up from 39.9% at June 30, 2026.
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
Red Violet Reports Third-Quarter Net Income of $5.45 Million
EARNINGS | Nov 04, 2026, 09:08 PM UTC
L
HBR Realty Agrees to Sell Stakes in Four Properties
HBR Realty agreed to sell stakes in four properties.
MNA | Nov 04, 2026, 09:08 PM UTC
M
ParkOhio Reports Record Q3 2026 Sales, Raises FY Outlook
Park-Ohio Holdings announced third-quarter 2026 results and raised its fiscal 2026 sales and adjusted EPS outlook, citing continued strong demand across diversified end markets.
EARNINGS | Nov 04, 2026, 09:08 PM UTC
L
Klaviyo Authorizes Up to $300 Million in Share Repurchases
Klaviyo authorized repurchases of up to $300 million of Series A common stock. Its prior $500 million authorization was completed in October. The supplied text also reports Q3 revenue growth of 25% year over year but pro
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
BYMA Buys Back Shares for 212 Million Pesos
Bolsas y Mercados Argentinos bought back 1,000,000 shares for 212 million pesos.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Tigo Energy Reports Third-Quarter 2026 Financial Results
Tigo Energy reported unaudited results for the third quarter and nine months ended September 30, 2026, and fourth-quarter financial guidance.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
QuinStreet Reports First-Quarter Adjusted EPS
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
Arm Holdings Reports Second-Quarter Fiscal 2027 Results
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
TrueBlue Reports Third-Quarter EPS
EARNINGS | Nov 04, 2026, 09:08 PM UTC
L
Barclays Bank files Form 424B2
Barclays Bank PLC filed a Form 424B2.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Warrior Met Coal Files Form 8-K
Warrior Met Coal filed a Form 8-K on November 4; the filing details are not provided.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Green Thumb Industries Reports Q3 Revenue of USD 324.4 Million
Q3 EBITDA was USD 59.3 million. Revenue was above the supplied IBES estimate of USD 308 million.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Sezzle files Form 8-K
Sezzle filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
TrueBlue Reports Third-Quarter Net Income of $9.24 Million
EARNINGS | Nov 04, 2026, 09:08 PM UTC
L
Pattern Group files Form 8-K
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Orthofix Medical Form 4 Filed by Patrick Fisher
A Form 4 for Orthofix Medical Inc. was filed by Patrick Fisher for Nov. 2.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
QuinStreet reports $17M net income in first quarter
EARNINGS | Nov 04, 2026, 09:08 PM UTC
L
Altimmune Insider Form 4 Filed for Nov. 2
A Form 4 for Altimmune, Inc., filed by Alex G. Howarth, covers Nov. 2. The filing date shown is November 4.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
QuinStreet Reports First-Quarter EPS
EARNINGS | Nov 04, 2026, 09:08 PM UTC
M
Kimball Electronics Reports Q1 Results, Reiterates FY2027 Guidance
Kimball Electronics reported results for the quarter ended September 30, 2026, and reiterated its fiscal 2027 guidance, with sales expected at the high end of the range.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Red Cedar Investment files Form 13F-HR for September 30
Red Cedar Investment filed a Form 13F-HR for the period ended September 30.
EQUITY | Nov 04, 2026, 09:08 PM UTC
L
Safety Insurance Group Q3 Net Income Rises to $30.0M
Q3 2026 net income was $30.0 million, or $2.05 per diluted share, versus $28.3 million and $1.91 in Q3 2025. The board approved a $0.92 quarterly dividend payable December 15, 2026, to holders of record December 1.
EARNINGS | Nov 04, 2026, 09:08 PM UTC
L
Frontier Group Holdings Form 3 Filed for Oct. 27
Fenner James R. filed a Form 3 for Frontier Group Holdings, dated Oct. 27. The filing date is shown as November 4, but the year is truncated.
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
Pacific Biosciences reports third-quarter revenue of $40.6 million
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Pacific Biosciences Reports $37.8M Third-Quarter Loss
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Metals Creek Files for Approval of $800,000 Flow-Through Placement
Metals Creek Resources says it filed documents with the TSX Venture Exchange seeking final approval to close its $800,000 flow-through private placement.
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Pacific Biosciences reports Q3 loss per share
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Arm Says AGI CPU Orders Extend Through CY27, Deliveries on Track
Arm says its AGI CPU has purchase orders extending through CY27, with first commercial deliveries on track for fiscal Q4.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
IM Cannabis Closes USD 1.2 Million Convertible Note Offering
IM Cannabis closed a USD 1.2 million convertible note offering.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Capital One Financial Form 144 Filed by Richard D. Fairbank
A Form 144 for Capital One Financial was filed by Richard D. Fairbank.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Rapid7 reports third-quarter EPS
EARNINGS | Nov 04, 2026, 09:07 PM UTC
M
Arcus Biosciences Reports Third-Quarter 2026 Financial Results and Pipeline Update
Arcus Biosciences reported financial results for the third quarter ended September 30, 2026, and provided a pipeline update.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
HMH Holding files Form 10-Q for period ended September 30
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Klaviyo Reports Third-Quarter Results
Klaviyo announced results for the third quarter ended September 30, 2026.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Safety Insurance Group files Form 8-K
Safety Insurance Group filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Edgewise Reports $1.17 Billion Third-Quarter Net Income
Edgewise reported third-quarter 2026 net income of $1.17 billion, versus a $40.7 million net loss a year earlier, reflecting a gain on the sale of its sevasemten program and muscular dystrophy business. Cash, cash equiva
EARNINGS | Nov 04, 2026, 09:07 PM UTC
L
PTC Inc. files Form 8-K
PTC Inc. filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Upland Software Files Form 8-K
Upland Software filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Accuray files Form 8-K
Accuray filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
BofA Finance LLC files Form 424B2
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Rapid7 Reports Third-Quarter Revenue of $212.4 Million
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Beyond Retail Equity files Form D
Beyond Retail Equity filed a Form D on November 4.
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Sturm Ruger Reports Third-Quarter Net Income of $5.81 Million
EARNINGS | Nov 04, 2026, 09:07 PM UTC
M
Rapid7 reports third-quarter adjusted earnings per share
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Aris Mining Reports Q3 2026 Results
Aris Mining announced financial and operating results for the three and nine months ended September 30, 2026. Amounts are in U.S. dollars unless otherwise indicated.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Sturm Ruger Reports Third-Quarter EPS
EARNINGS | Nov 04, 2026, 09:07 PM UTC
L
LegalZoom files Form 8-K
LegalZoom filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Qualcomm files Form 8-K
Qualcomm filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Goldman Sachs files Form 424B2
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Dianthus Therapeutics files Form 8-K
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Cirrus Logic files Form 10-Q
Cirrus Logic filed a Form 10-Q for Sep. 26.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Nasdaq Notifies Bayview Acquisition of Planned Delisting
Nasdaq said on October 30, 2026, it would proceed with removing Bayview Acquisition’s securities from listing after declining to review decisions setting a June 19, 2026 deadline for the company’s business combination an
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Accuray Reports First-Quarter Revenue of $86.5 Million
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
GRAIL Reports Q3 Revenue of $37.5M vs. $44.2M FactSet Estimate
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
QuinStreet Reports Record Fiscal First Quarter 2027 Results
QuinStreet reported record fiscal first-quarter results for the period ended September 30, 2026.
EARNINGS | Nov 04, 2026, 09:07 PM UTC
L
Braemar Hotels & Resorts files Form 8-K
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Tanger Reports Third-Quarter Revenue of $157.7 Million
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Tanger reports third-quarter EPS
EARNINGS | Nov 04, 2026, 09:07 PM UTC
L
Tanger Reports Third-Quarter Net Income of $33.7 Million
EARNINGS | Nov 04, 2026, 09:07 PM UTC
M
Chime Reports 32% Revenue Growth, Raises 2026 Outlook
Chime reported Q3 2026 results, including its third consecutive quarter of GAAP profitability, and raised its fourth-quarter and full-year 2026 outlook. Specific guidance figures were not included.
EARNINGS | Nov 04, 2026, 09:07 PM UTC
M
Design Therapeutics Reports Third-Quarter 2026 Results and Business Updates
The company said a registrational plan update for DT-216P2 is anticipated in Q4 2026; the supplied text also mentions 12-week RESTORE-FA data.
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Pattern Group Raises 2026 Revenue Outlook to $3.50B–$3.52B
Pattern Group reported Q3 2026 revenue of $886 million, up 38% year over year, and net revenue retention of 127%. It raised its 2026 adjusted EBITDA outlook to $219 million–$220 million.
EARNINGS | Nov 04, 2026, 09:07 PM UTC
L
STAAR Surgical files Form 8-K
EQUITY | Nov 04, 2026, 09:07 PM UTC
M
Fastly Announces Third-Quarter 2026 Financial Results
Fastly reported results for the quarter ended September 30, 2026. The available text provides no financial figures.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Tegma Fiscal Council Deems Third-Quarter 2026 Financial Statements Adequate
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Winchester Bancorp files Form 10-Q for quarter ended Sept. 30
Winchester Bancorp filed a Form 10-Q. The filing covers the period ended Sept. 30.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Sprout Social Files Form 10-Q for Quarter Ended September 30
EQUITY | Nov 04, 2026, 09:07 PM UTC